Who owns the CYSTALENS trademark?

The CYSTALENS trademark is owned by Diopter Corporation.

What class is the CYSTALENS trademark registered in?

The CYSTALENS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for CYSTALENS?

The USPTO serial number for CYSTALENS is 90490277.

What is the registration number for CYSTALENS?

CYSTALENS is registered under USPTO registration number 6890401.

Sealvo

Home Search: CYSTALENSCYSTALENS #90490277

Back

Updated Oct 28, 2026·8 searches this week

View on USPTO TSDR Find similar marks

CYS

USPTO Trademark Record

REGISTERED

CYSTALENS

SN 90490277·Reg 6890401·Filed Jan 26, 2021

Owner Diopter Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

CYSTALENS (Serial No. 90490277), Registration No. 6890401, is a registered US trademark filed on Jan 26, 2021 by Diopter Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: November 01, 2028

Mark Intelligence

CYSTALENS (Reg. #6890401) is a registered US trademark that has been protecting its owner, Diopter Corporation, since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 26, 2021

SERIAL

90490277

REG#

6890401

REGISTERED

Nov 01, 2022

Filing Information

StatusREGISTERED

Filing DateJan 26, 2021

Serial Number90490277

Registration No.6890401

Registration DateNov 01, 2022

Status DateNov 01, 2022

Published for OppositionMar 08, 2022

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jun 01, 2022

First use in commerce: Jul 01, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

REGISTERED-PRINCIPAL REGISTER

Nov 01, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 01, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 30, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 29, 2022

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 19, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Sep 19, 2022

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Sep 06, 2022

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 06, 2022

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 03, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 08, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 08, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 16, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 03, 2022

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Feb 02, 2022

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 31, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Jan 28, 2022

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jan 28, 2022

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 28, 2022

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jan 28, 2022

EXAMINER'S AMENDMENT ENTERED

NON-FINAL ACTION WRITTEN

Aug 12, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 12, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 12, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 11, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 28, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 29, 2021

NEW APPLICATION ENTERED

CYSTALENS

Run a conflict check

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company